606 related articles for article (PubMed ID: 30111563)
1. Neuralized E3 Ubiquitin Protein Ligase 3 Is an Inducible Antiviral Effector That Inhibits Hepatitis C Virus Assembly by Targeting Viral E1 Glycoprotein.
Zhao Y; Cao X; Guo M; Wang X; Yu T; Ye L; Han L; Hei L; Tao W; Tong Y; Xu Y; Zhong J
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111563
[TBL] [Abstract][Full Text] [Related]
2. E3 ubiquitin ligase NEURL3 promotes innate antiviral response through catalyzing K63-linked ubiquitination of IRF7.
Qi F; Zhang X; Wang L; Ren C; Zhao X; Luo J; Lu D
FASEB J; 2022 Aug; 36(8):e22409. PubMed ID: 35792897
[TBL] [Abstract][Full Text] [Related]
3. Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.
Haddad JG; Rouillé Y; Hanoulle X; Descamps V; Hamze M; Dabboussi F; Baumert TF; Duverlie G; Lavie M; Dubuisson J
J Virol; 2017 Apr; 91(8):. PubMed ID: 28179528
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of Viral Glycoprotein Targeting by Membrane-Associated RING-CH Proteins.
Lun CM; Waheed AA; Majadly A; Powell N; Freed EO
mBio; 2021 Mar; 12(2):. PubMed ID: 33727347
[TBL] [Abstract][Full Text] [Related]
5. Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.
Majid AM; Ezelle H; Shah S; Barber GN
J Virol; 2006 Jul; 80(14):6993-7008. PubMed ID: 16809305
[TBL] [Abstract][Full Text] [Related]
6. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
[TBL] [Abstract][Full Text] [Related]
7. Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication.
Tamura K; Oue A; Tanaka A; Shimizu N; Takagi H; Kato N; Morikawa A; Hoshino H
Microbes Infect; 2005 Jan; 7(1):29-40. PubMed ID: 15716060
[TBL] [Abstract][Full Text] [Related]
8. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
[TBL] [Abstract][Full Text] [Related]
9. Innate and adaptive immune responses in HCV infections.
Heim MH; Thimme R
J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
[TBL] [Abstract][Full Text] [Related]
10. Ficolin-2 inhibits hepatitis C virus infection, whereas apolipoprotein E3 mediates viral immune escape.
Zhao Y; Ren Y; Zhang X; Zhao P; Tao W; Zhong J; Li Q; Zhang XL
J Immunol; 2014 Jul; 193(2):783-96. PubMed ID: 24928988
[TBL] [Abstract][Full Text] [Related]
11. Structure and Function of the Hepatitis C Virus Envelope Glycoproteins E1 and E2: Antiviral and Vaccine Targets.
Freedman H; Logan MR; Law JL; Houghton M
ACS Infect Dis; 2016 Nov; 2(11):749-762. PubMed ID: 27933781
[TBL] [Abstract][Full Text] [Related]
12. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
13. Innate immunity and HCV.
Heim MH
J Hepatol; 2013 Mar; 58(3):564-74. PubMed ID: 23063572
[TBL] [Abstract][Full Text] [Related]
14. PJA1 Coordinates with the SMC5/6 Complex To Restrict DNA Viruses and Episomal Genes in an Interferon-Independent Manner.
Xu W; Ma C; Zhang Q; Zhao R; Hu D; Zhang X; Chen J; Liu F; Wu K; Liu Y; Wu J
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185588
[TBL] [Abstract][Full Text] [Related]
15. Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector.
Ezelle HJ; Markovic D; Barber GN
J Virol; 2002 Dec; 76(23):12325-34. PubMed ID: 12414973
[TBL] [Abstract][Full Text] [Related]
16. Characterization of pseudotype VSV possessing HCV envelope proteins.
Matsuura Y; Tani H; Suzuki K; Kimura-Someya T; Suzuki R; Aizaki H; Ishii K; Moriishi K; Robison CS; Whitt MA; Miyamura T
Virology; 2001 Aug; 286(2):263-75. PubMed ID: 11485395
[TBL] [Abstract][Full Text] [Related]
17. Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.
Vausselin T; Séron K; Lavie M; Mesalam AA; Lemasson M; Belouzard S; Fénéant L; Danneels A; Rouillé Y; Cocquerel L; Foquet L; Rosenberg AR; Wychowski C; Meuleman P; Melnyk P; Dubuisson J
J Virol; 2016 Oct; 90(19):8422-34. PubMed ID: 27412600
[TBL] [Abstract][Full Text] [Related]
18. Identification of Cholesterol 25-Hydroxylase as a Novel Host Restriction Factor and a Part of the Primary Innate Immune Responses against Hepatitis C Virus Infection.
Xiang Y; Tang JJ; Tao W; Cao X; Song BL; Zhong J
J Virol; 2015 Jul; 89(13):6805-16. PubMed ID: 25903345
[TBL] [Abstract][Full Text] [Related]
19. Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver.
Mitchell AM; Stone AE; Cheng L; Ballinger K; Edwards MG; Stoddard M; Li H; Golden-Mason L; Shaw GM; Khetani S; Rosen HR
mBio; 2015 Feb; 6(2):e02510. PubMed ID: 25714713
[TBL] [Abstract][Full Text] [Related]
20. NLRX1 Mediates MAVS Degradation To Attenuate the Hepatitis C Virus-Induced Innate Immune Response through PCBP2.
Qin Y; Xue B; Liu C; Wang X; Tian R; Xie Q; Guo M; Li G; Yang D; Zhu H
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
